No disclosed counterparties: SCI, EVI.
| Stage | SCI | % of rev | EVI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $122M | 100.00% | SCI ×9.09 |
| Gross profit | $272M | 24.59% | $38M | 31.57% | EVI +7.0pp |
| Operating income | $253M | 22.84% | $6M | 4.63% | SCI +18.2pp |
| Pre-tax income | $189M | 17.05% | $5M | 3.83% | SCI +13.2pp |
| Net income | $141M | 12.76% | $3M | 2.25% | SCI +10.5pp |
| Stage | SCI | EVI | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $122M100.00% | SCI ×9.09 |
| Gross profit | 24.59%$272M | 31.57%$38M | EVI +7.0pp |
| Operating income | 22.84%$253M | 4.63%$6M | SCI +18.2pp |
| Pre-tax income | 17.05%$189M | 3.83%$5M | SCI +13.2pp |
| Net income |
| 12.76%$141M |
| 2.25%$3M |
| SCI +10.5pp |